[{"Assets_0_Q3_USD":253983000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":23582000.0,"NetIncomeLoss_3_Q3_USD":18415000.0,"NetIncomeLoss_1_Q3_USD":6825000.0,"PaymentsOfDividendsCommonStock_3_Q3_USD":15870000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":42758000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":42712000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":42307000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":42349000.0,"StockholdersEquity_0_Q3_USD":175127000.0,"EarningsPerShareBasic_1_Q3_USD":0.16,"EarningsPerShareBasic_3_Q3_USD":0.44,"EarningsPerShareDiluted_1_Q3_USD":0.16,"EarningsPerShareDiluted_3_Q3_USD":0.43,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20180809"}]